Prof dr Karel Allegaert, MD, PhD is pediatrician-neonatologist and clinical pharmacologist. He is Professor at KU Leuven and Consultant at Erasmus MC Rotterdam. In his clinical research activities, he has focused mainly on perinatal and developmental pharmacology, with a specific interest in perinatal and neonatal clinical pharmacology and the relevant co-variates (maturational, non-maturational, pharmacogenetics, disease-related, pregnancy-related) of pharmacokinetics, and the subsequent use of in vivo datasets to develop prediction models.
More recently, his research line has further expanded to in vitro models (placenta, renal tubular cells), in vivo models (bronchopulmonary dysplasia rabbit model) and ng term pharmacovigilance in former preterm neonates. Related to these clinical research activities, he has also expertise with DSMB activities, and consultancies to individual companies or authorities, and is involved in several international networks like IMIc4c, the International Neonatal Consortium, and learned societies (ESPR, IUPHAR) or editorial boards of relevant journals to the topic.